Concepts (141)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Adaptation, Physiological
- Adaptive Immunity
- Adolescent
- Adult
- Aerosols
- Africa
- Age Factors
- Aged
- Aged, 80 and over
- Aging
- Air Microbiology
- Aircraft
- Alemtuzumab
- Animals
- Antibodies, Neutralizing
- Antibodies, Viral
- Antibody-Dependent Enhancement
- Anti-Infective Agents
- Antineoplastic Agents, Immunological
- Asymptomatic Diseases
- Asymptomatic Infections
- Autopsy
- Bacterial Infections
- Betacoronavirus
- Biomarkers
- Biomarkers, Tumor
- Blood Banks
- Calibration
- Carrier State
- CD52 Antigen
- China
- Climate Change
- Clinical Laboratory Techniques
- Clinical Protocols
- Clinical Trials as Topic
- Clinical Trials, Phase I as Topic
- Cohort Studies
- Communicable Disease Control
- Communicable Diseases, Emerging
- Computer Simulation
- Coronavirus Infections
- Cross Reactions
- Cross-Sectional Studies
- Cyclophosphamide
- Decision Support Techniques
- Disaster Planning
- Disease Susceptibility
- Disease Transmission, Infectious
- Double-Blind Method
- Emigration and Immigration
- Epidemics
- Epidemiologic Research Design
- Epidemiological Monitoring
- Evolution, Molecular
- Female
- Forecasting
- Georgia
- Global Health
- Health Status
- Heart Injuries
- Homes for the Aged
- Humans
- Immune Evasion
- Immunity, Herd
- Immunity, Heterologous
- Immunity, Humoral
- Immunity, Innate
- Immunization Schedule
- Immunogenicity, Vaccine
- Immunoglobulins, Intravenous
- Incidence
| - Influenza A Virus, H1N1 Subtype
- Influenza Vaccines
- Influenza, Human
- Injury Severity Score
- Interdisciplinary Communication
- International Cooperation
- Kinetics
- Limit of Detection
- Lymphoma, Non-Hodgkin
- Male
- Mass Screening
- Measles
- Measles Vaccine
- Middle Aged
- Models, Animal
- Models, Theoretical
- Molecular Diagnostic Techniques
- Mutation
- Neutralization Tests
- Nucleic Acid Amplification Techniques
- Nursing Homes
- Pandemics
- Patient Selection
- Personal Protective Equipment
- Personnel Staffing and Scheduling
- Phenotype
- Pneumonia, Viral
- Point-of-Care Testing
- Polymerase Chain Reaction
- Population Surveillance
- Prevalence
- Program Development
- Protein Domains
- Public Health Administration
- Public Health Surveillance
- Reagent Kits, Diagnostic
- Real-Time Polymerase Chain Reaction
- Reproducibility of Results
- Research Design
- Respiratory Tract Infections
- Retrospective Studies
- Reverse Transcriptase Polymerase Chain Reaction
- Risk Assessment
- Seasons
- Selection, Genetic
- Sensitivity and Specificity
- Seroepidemiologic Studies
- Serologic Tests
- Severity of Illness Index
- Specimen Handling
- Spike Glycoprotein, Coronavirus
- Strategic Stockpile
- Time Factors
- T-Lymphocytes
- Travel
- United Kingdom
- United Nations
- Vaccination
- Vaccination Coverage
- Vaccination Refusal
- Vaccines
- Vaccines, Attenuated
- Viral Load
- Viral Vaccines
- Virus Diseases
- Vulnerable Populations
- Weather
- Wounds, Gunshot
- Young Adult
- Zoonoses
|
Mina's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(130)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_